Publication | Closed Access

Regulatory T cell inhibition by dasatinib is associated with natural killer cell differentiation and a favorable molecular response—The final results of the D-first study

Cancer ImmunosurveillanceImmune Cell DevelopmentT-regulatory CellImmunologyTumor ImmunityImmune RegulationT Cell ImmunityCd4 T Cell ResponsesD-first StudyTolerance InductionCellular Immune ResponseImmunotherapyMedicineCell BiologyCell SignalingRegulatory T Cell BiologyT Cell Biology